Accelerate Diagnostics
AXDX
AXDX was delisted on the 14th of May, 2025.
123 hedge funds and large institutions have $448M invested in Accelerate Diagnostics in 2020 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 21 reducing their positions, and 9 closing their positions.
156% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 9
110% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 21
82% more capital invested
Capital invested by funds: $246M → $448M (+$202M)
12% more funds holding
Funds holding: 110 → 123 (+13)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
34% less call options, than puts
Call options by funds: $5.31M | Put options by funds: $8.09M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baird Financial Group
Milwaukee,
Wisconsin
|
+$4.18M |
| 2 |
Morgan Stanley
New York
|
+$4.18M |
| 3 |
SM
Senvest Management
New York
|
+$2.6M |
| 4 |
BlackRock
New York
|
+$1.58M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.46M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$11.9M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.57M |
| 3 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
-$1.97M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.82M |
| 5 |
CC
Chicago Capital
Chicago,
Illinois
|
-$1.4M |
AXDX Hedge Fund Activity: Q2 2020 in Review
123 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q2 2020, worth a combined $448M — up 82% from $246M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new AXDX positions and 9 closed out — a net gain of 14 holders — while 44 added to existing stakes and 21 trimmed.
The largest buyer was Baird Financial Group, adding an estimated $4.18M. The largest seller was Credit Suisse, cutting an estimated $11.9M.
- 123 institutional investors held Accelerate Diagnostics (AXDX) as of Q2 2020, up from 110 in Q1 2020.
- Funds reported $448M of Accelerate Diagnostics stock for Q2 2020, up 82% quarter-over-quarter.
- 23 funds opened new Accelerate Diagnostics positions in Q2 2020 and 9 closed out, a net change of +14 holders.
- The largest Accelerate Diagnostics buyer in Q2 2020 was Baird Financial Group, an estimated $4.18M added.
- The largest Accelerate Diagnostics seller in Q2 2020 was Credit Suisse, an estimated $11.9M sold.
Based on aggregated 13F filings for Q2 2020.